Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: EXACT SCIENCES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-02-11 to 2025-09-30
Current total value of award: $24177.72
Description: LABORATORY ONCOTYPE DX TESTS THAT SCORE & INDICATE A PATIENT'S RISK OF BREAST CANCER RECURRENCE.